Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-36,000
Closed -$3.32M – 7957
2020
Q1
$3.32M Buy
+36,000
New +$4.64M ﹤0.01% 2283
2019
Q4
– Sell
-11,200
Closed -$1.45M – 8114
2019
Q3
$1.45M Buy
11,200
+6,200
+124% +$805K ﹤0.01% 3624
2019
Q2
$645K Buy
+5,000
New +$672K ﹤0.01% 4103
2016
Q4
– Sell
-8,000
Closed -$1.09M – 7775
2016
Q3
$1.09M Buy
+8,000
New +$1.11M ﹤0.01% 3352
2015
Q2
– Sell
-800
Closed -$112K – 8499
2015
Q1
$112K Hold
800
– – ﹤0.01% 5321
2014
Q4
$103K Buy
+800
New +$101K ﹤0.01% 5674

Other funds holding BXP

UBS Group's BXP Position: Q3 2026 in Review

UBS Group reduced its BXP (BXP) stake by 15% in Q3 2026, selling an estimated $15.5M and leaving 1,277,061 shares worth $78M. The position accounts for 0.01% of the portfolio, ranked #1285.

UBS Group first reported a position in BXP in Q4 2014 and has held it in 48 quarters since. The position peaked at $100M in Q2 2026. 548 funds tracked by Wall St. Rank hold BXP as of Q3 2026.

  • UBS Group held 1,277,061 shares of BXP worth $78M as of Q3 2026.
  • UBS Group sold 229,399 BXP shares in Q3 2026, an estimated $15.5M.
  • BXP made up 0.01% of UBS Group's portfolio in Q3 2026, its #1285 holding.
  • UBS Group first reported a position in BXP in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's BXP position peaked at $100M in Q2 2026.
  • 548 funds tracked by Wall St. Rank held BXP as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.